Zhang Jun, Tran Quyen, Lattard Virginie, Cashman John R
Human Biomolecular Research Institute, 5310 Eastgate Mall, San Diego, CA 92121, USA.
Pharmacogenetics. 2003 Aug;13(8):495-500. doi: 10.1097/00008571-200308000-00007.
The primary genetic form of trimethylaminuria (TMAU) is caused by inherited defects in the flavin-containing monooxygenase 3 (FMO3) gene. Defective FMO3 has a decreased ability to catalyze the N-oxygenation of the dietary-derived malodourous amine, trimethylamine. We report two novel deleterious mutations identified in two unrelated individuals affected by the disorder. Sequence analysis of the FMO3 coding exons amplified from genomic DNA revealed that the mutation from individual 1 was heterozygous for a G>A missense mutation in exon 2 of the FMO3 gene. The mutation changed a GAG encoding Glu at codon 32 to AAG encoding Lys. Wild-type and mutant E32K FMO3 were expressed in Escherichia coli as maltose binding-fusion proteins and assayed for their ability to catalyze oxygenation of various FMO3 substrates. The results showed that the E32K mutation abrogated the catalytic activity of the enzyme. Individual 2 was identified as heterozygous for the P153L mutation. In addition, individual 2 was also heterozygous for a novel single nucleotide deletion of A191 in exon 3 at codon 64. The deletion resulted in a frame shift and caused premature termination of the FMO3 gene immediately after codon 65. Family pedigree analysis revealed that the P153L and the deletion mutation were carried on different alleles for this individual. Therefore, both alleles of the FMO3 gene for individual 2 were affected by mutations abolishing the catalytic activity of the enzyme, explaining the severe TMAU condition. The two deleterious mutations reported herein were rare mutations with estimated allelic frequencies of less than 1%.
三甲胺尿症(TMAU)的主要遗传形式是由含黄素单加氧酶3(FMO3)基因的遗传缺陷引起的。有缺陷的FMO3催化饮食来源的恶臭胺三甲胺N-氧化的能力下降。我们报告了在两名受该疾病影响的无关个体中发现的两个新的有害突变。对从基因组DNA扩增的FMO3编码外显子进行序列分析,结果显示个体1的突变是FMO3基因外显子2中G>A错义突变的杂合子。该突变将编码第32位密码子Glu的GAG变为编码Lys的AAG。野生型和突变型E32K FMO3在大肠杆菌中作为麦芽糖结合融合蛋白表达,并检测它们催化各种FMO3底物氧化的能力。结果表明,E32K突变消除了该酶的催化活性。个体2被鉴定为P153L突变的杂合子。此外,个体2在第3外显子第64位密码子处还存在一个新的A191单核苷酸缺失的杂合子。该缺失导致移码,并在第65位密码子后立即导致FMO3基因提前终止。家系分析显示,该个体的P153L和缺失突变位于不同等位基因上。因此,个体2的FMO3基因的两个等位基因均受突变影响,导致酶的催化活性丧失,这解释了其严重的TMAU病情。本文报道的这两个有害突变是罕见突变,估计等位基因频率小于1%。